Eris Lifesciences Ltd vs Starsource Multitrade Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1386 as of 08 May 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of Starsource Multitrade Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of Starsource Multitrade Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Starsource Multitrade Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Starsource Multitrade Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Starsource Multitrade Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Starsource Multitrade Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Starsource Multitrade Ltd

Starsource Multitrade Limited was initially established on August 17, 1942 under the name 'Chemo Pharma Laboratories Limited'.
Name of the Company is given a change in name with due approval from Registrar of Companies effected on August 12, 2025.
Initially, the Company had been making Pharmaceuticals and also diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues.
Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential.
The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals. The existing Main Objects of Clause III (A) be altered by replacing the same with the following new Clause to carry on the business of buying, selling, reselling, importing, exporting, transporting, storing, promoting, marketing or supplying, trading, dealing in any manner whatsoever in all type of goods and commodities on retail as well as on wholesale basis in India or elsewhere during the year 2025.

FAQs for the comparison of ERIS Lifesciences Ltd and Starsource Multitrade Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Starsource Multitrade Ltd?

Market cap of ERIS Lifesciences Ltd is 19,169 Cr while Market cap of Starsource Multitrade Ltd is 17 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Starsource Multitrade Ltd?

The stock performance of ERIS Lifesciences Ltd and Starsource Multitrade Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Starsource Multitrade Ltd?

As of May 8, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1383.65. On the other hand, Starsource Multitrade Ltd stock price is INR ₹115.75.

How do dividend payouts of ERIS Lifesciences Ltd and Starsource Multitrade Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Starsource Multitrade Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.